Evidence map›Paper›PMID 42488996›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2026

Active pH Modulation by Proton Channel-Peptide Nucleic Acid Complex for Effective siRNA Endosomal Escape.

Seongmin Ga, Nam Hyeong Kim, Si Yeon Ryu, Kyeonghyun Kim, Eun Sung Kang, Hayeon Bae, Seungmin Ryu, Suhyeon Kim, Yeontae Jang, Bok-Soo Lee and 7 more

Abstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Seongmin GaSKKU Advanced Institute of Nanotechnology (SAINT), Sungkyunkwan University (SKKU), Suwon, Gyeonggi-do, Republic of Korea.ORCID https://orcid.org/0009-0004-9200-1189
Nam Hyeong KimSKKU Advanced Institute of Nanotechnology (SAINT), Sungkyunkwan University (SKKU), Suwon, Gyeonggi-do, Republic of Korea.
Si Yeon RyuSKKU Advanced Institute of Nanotechnology (SAINT), Sungkyunkwan University (SKKU), Suwon, Gyeonggi-do, Republic of Korea.
Kyeonghyun KimSKKU Advanced Institute of Nanotechnology (SAINT), Sungkyunkwan University (SKKU), Suwon, Gyeonggi-do, Republic of Korea.
Eun Sung KangSKKU Advanced Institute of Nanotechnology (SAINT), Sungkyunkwan University (SKKU), Suwon, Gyeonggi-do, Republic of Korea.
Hayeon BaeSKKU Advanced Institute of Nanotechnology (SAINT), Sungkyunkwan University (SKKU), Suwon, Gyeonggi-do, Republic of Korea.
Seungmin RyuDepartment of Biomedical Engineering, Sungkyunkwan University (SKKU), Suwon, Republic of Korea.
Suhyeon KimSKKU Advanced Institute of Nanotechnology (SAINT), Sungkyunkwan University (SKKU), Suwon, Gyeonggi-do, Republic of Korea.ORCID https://orcid.org/0000-0001-8375-2491
Yeontae JangSchool of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.
Bok-Soo LeeSKKU Advanced Institute of Nanotechnology (SAINT), Sungkyunkwan University (SKKU), Suwon, Gyeonggi-do, Republic of Korea.
Jiyoung NamIMNEWRUN INC., Suwon, Republic of Korea.
Minah SuhDepartment of Biomedical Engineering, Sungkyunkwan University (SKKU), Suwon, Republic of Korea.ORCID https://orcid.org/0000-0002-1393-3550
Jaecheol LeeSchool of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.ORCID https://orcid.org/0000-0002-2070-7463
Seung-Gu KangSKKU Advanced Institute of Nanotechnology (SAINT), Sungkyunkwan University (SKKU), Suwon, Gyeonggi-do, Republic of Korea.
Jaekyung HyunSchool of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.
Huong T KratochvilDepartment of Chemistry, College of Arts and Sciences, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.ORCID https://orcid.org/0000-0001-8039-6823
Yong Ho KimSKKU Advanced Institute of Nanotechnology (SAINT), Sungkyunkwan University (SKKU), Suwon, Gyeonggi-do, Republic of Korea.ORCID https://orcid.org/0000-0002-9106-3298

Funding

Korean government RS-2023-NR077270Ministry of Science and ICT RS-2024-00444177National Research Foundation (NRF) of Korea RS-2024-00440289 /RS-2024-00440614
6 · The paper itself

Abstract

Small interfering RNA (siRNA) has shown great potential for treating various genetic diseases, but lysosomal degradation limits its bioavailability. Here, we present the design of a Channel-PNA-siRNA (CPR) complex that facilitates endosomal escape by actively inducing osmotic rupture of the endosomes. Our design utilizes the transmembrane domain of the M2 proton channel (M2TM) to facilitate proton influx into the liposome while serving as an anchor for siRNA; this surface tethering is mediated by a peptide nucleic acid (PNA) linker that enables stable, non-covalent binding. Our results indicate that the CPR complex interrupts the endosomal pathway, effectively reducing the colocalization of delivered siRNA with lysosomes and enhancing gene regulation efficiency. Furthermore, we demonstrate dual-target gene knockdown using CPR-tethered liposomes by encapsulating additional siRNAs in the empty cavity of the liposome. These findings highlight the therapeutic potential of modulating the endosomal pH environment to prevent lysosomal degradation, suggesting that the CPR nanocarrier design could serve as a versatile platform for targeted RNA delivery.

Indexed as

EndosomesPeptide Nucleic AcidsRNA, Small InterferingHeLa CellsHumansHydrogen-Ion ConcentrationLiposomesProtonsLiposomesPeptide Nucleic AcidsProtonsRNA, Small Interferingendosomal escapeM2 proton channelmultiplexed gene silencingpeptide nucleic acidsiRNA drug

Identifiers

PMID42488996
PMCPMC13592411

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.